Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06194695
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-22
Brief Title:
DEB-TACE Lenvatinib and Anti-PDL1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma
Sponsor:
Ze-yang Ding MD
Organization:
Tongji Hospital
Organization Data
Organization:
Tongji Hospital
Class:
OTHER
Study ID:
TJ-IRB20221203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ze-yang Ding MD
Lead Sponsor Class:
OTHER
Responsible Party:
Ze-yang Ding MD
Responsible Party Title:
Prof
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Tongji Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chinese Cooperative Group of Liver Cancer | OTHER |
| Geneplus-Beijing Co Ltd | INDUSTRY |